BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17100994)

  • 21. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
    Borg A; Haile RW; Malone KE; Capanu M; Diep A; Törngren T; Teraoka S; Begg CB; Thomas DC; Concannon P; Mellemkjaer L; Bernstein L; Tellhed L; Xue S; Olson ER; Liang X; Dolle J; Børresen-Dale AL; Bernstein JL
    Hum Mutat; 2010 Mar; 31(3):E1200-40. PubMed ID: 20104584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer.
    Kim H; Cho DY; Choi DH; Choi SY; Shin I; Park W; Huh SJ; Han SH; Lee MH; Ahn SH; Son BH; Kim SW; ; Haffty BG
    Breast Cancer Res Treat; 2012 Aug; 134(3):1315-26. PubMed ID: 22798144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
    Amendola LM; Dorschner MO; Robertson PD; Salama JS; Hart R; Shirts BH; Murray ML; Tokita MJ; Gallego CJ; Kim DS; Bennett JT; Crosslin DR; Ranchalis J; Jones KL; Rosenthal EA; Jarvik ER; Itsara A; Turner EH; Herman DS; Schleit J; Burt A; Jamal SM; Abrudan JL; Johnson AD; Conlin LK; Dulik MC; Santani A; Metterville DR; Kelly M; Foreman AK; Lee K; Taylor KD; Guo X; Crooks K; Kiedrowski LA; Raffel LJ; Gordon O; Machini K; Desnick RJ; Biesecker LG; Lubitz SA; Mulchandani S; Cooper GM; Joffe S; Richards CS; Yang Y; Rotter JI; Rich SS; O'Donnell CJ; Berg JS; Spinner NB; Evans JP; Fullerton SM; Leppig KA; Bennett RL; Bird T; Sybert VP; Grady WM; Tabor HK; Kim JH; Bamshad MJ; Wilfond B; Motulsky AG; Scott CR; Pritchard CC; Walsh TD; Burke W; Raskind WH; Byers P; Hisama FM; Rehm H; Nickerson DA; Jarvik GP
    Genome Res; 2015 Mar; 25(3):305-15. PubMed ID: 25637381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
    Houdayer C; Caux-Moncoutier V; Krieger S; Barrois M; Bonnet F; Bourdon V; Bronner M; Buisson M; Coulet F; Gaildrat P; Lefol C; Léone M; Mazoyer S; Muller D; Remenieras A; Révillion F; Rouleau E; Sokolowska J; Vert JP; Lidereau R; Soubrier F; Sobol H; Sevenet N; Bressac-de Paillerets B; Hardouin A; Tosi M; Sinilnikova OM; Stoppa-Lyonnet D
    Hum Mutat; 2012 Aug; 33(8):1228-38. PubMed ID: 22505045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classifying Variants of Undetermined Significance in BRCA2 with protein likelihood ratios.
    Karchin R; Agarwal M; Sali A; Couch F; Beattie MS
    Cancer Inform; 2008; 6():203-16. PubMed ID: 19043619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
    Lee MS; Green R; Marsillac SM; Coquelle N; Williams RS; Yeung T; Foo D; Hau DD; Hui B; Monteiro AN; Glover JN
    Cancer Res; 2010 Jun; 70(12):4880-90. PubMed ID: 20516115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
    Wagner TM; Hirtenlehner K; Shen P; Moeslinger R; Muhr D; Fleischmann E; Concin H; Doeller W; Haid A; Lang AH; Mayer P; Petru E; Ropp E; Langbauer G; Kubista E; Scheiner O; Underhill P; Mountain J; Stierer M; Zielinski C; Oefner P
    Hum Mol Genet; 1999 Mar; 8(3):413-23. PubMed ID: 9971877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An informatics approach to analyzing the incidentalome.
    Berg JS; Adams M; Nassar N; Bizon C; Lee K; Schmitt CP; Wilhelmsen KC; Evans JP
    Genet Med; 2013 Jan; 15(1):36-44. PubMed ID: 22995991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional assays for analysis of variants of uncertain significance in BRCA2.
    Guidugli L; Carreira A; Caputo SM; Ehlen A; Galli A; Monteiro AN; Neuhausen SL; Hansen TV; Couch FJ; Vreeswijk MP;
    Hum Mutat; 2014 Feb; 35(2):151-64. PubMed ID: 24323938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
    Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
    Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
    Hondow HL; Fox SB; Mitchell G; Scott RJ; Beshay V; Wong SQ; ; Dobrovic A
    BMC Cancer; 2011 Jun; 11():265. PubMed ID: 21702907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.
    Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS
    Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns and functional implications of rare germline variants across 12 cancer types.
    Lu C; Xie M; Wendl MC; Wang J; McLellan MD; Leiserson MD; Huang KL; Wyczalkowski MA; Jayasinghe R; Banerjee T; Ning J; Tripathi P; Zhang Q; Niu B; Ye K; Schmidt HK; Fulton RS; McMichael JF; Batra P; Kandoth C; Bharadwaj M; Koboldt DC; Miller CA; Kanchi KL; Eldred JM; Larson DE; Welch JS; You M; Ozenberger BA; Govindan R; Walter MJ; Ellis MJ; Mardis ER; Graubert TA; Dipersio JF; Ley TJ; Wilson RK; Goodfellow PJ; Raphael BJ; Chen F; Johnson KJ; Parvin JD; Ding L
    Nat Commun; 2015 Dec; 6():10086. PubMed ID: 26689913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
    Spearman AD; Sweet K; Zhou XP; McLennan J; Couch FJ; Toland AE
    J Clin Oncol; 2008 Nov; 26(33):5393-400. PubMed ID: 18824701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
    Thirthagiri E; Lee SY; Kang P; Lee DS; Toh GT; Selamat S; Yoon SY; Taib NA; Thong MK; Yip CH; Teo SH
    Breast Cancer Res; 2008; 10(4):R59. PubMed ID: 18627636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
    Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
    PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
    Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).
    Lecarpentier J; Noguès C; Mouret-Fourme E; Gauthier-Villars M; Lasset C; Fricker JP; Caron O; Stoppa-Lyonnet D; Berthet P; Faivre L; Bonadona V; Buecher B; Coupier I; Gladieff L; Gesta P; Eisinger F; Frénay M; Luporsi E; Lortholary A; Colas C; Dugast C; Longy M; Pujol P; Tinat J; ; Lidereau R; Andrieu N
    Breast Cancer Res; 2012 Jul; 14(4):R99. PubMed ID: 22762150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes.
    Menéndez M; Castellsagué J; Mirete M; Pros E; Feliubadaló L; Osorio A; Calaf M; Tornero E; del Valle J; Fernández-Rodríguez J; Quiles F; Salinas M; Velasco A; Teulé A; Brunet J; Blanco I; Capellá G; Lázaro C
    Breast Cancer Res Treat; 2012 Apr; 132(3):979-92. PubMed ID: 21735045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.